Discovery of the 2,3-Dihydrobenzopyrane-4-one as a Potent FTO Inhibitor against Obesity-Related Metabolic Diseases

Año publicación: 2025

Subir documento: https://drive.google.com/file/d/1drO4zWmgfbbutLQoEVkdJZLBRKYapkPv/view?usp=sharing

Nombre investigadores: Duo Ma, Xianan Liu, Xingxing Zhang, Yaling Hong, Yumeng Wang, Famin Zhang, Leran Du, Junjie Zhao, Quan Wang, Cui Chang, Wenhu Liu, Yan Lou, Xinhua Liu